ArticleBritish journal of cancer2026

Programmed death ligand 1 (PD-L1) PET/CT imaging to evaluate tumour saturation during atezolizumab treatment.

Jahlisa S Hooiveld-Noeken et al.PubMed ↗Publisher ↗

No numbers read from the abstract.